drugset / Trial / NCT06090721
DMT310-009 Topical in the Treatment of Acne Vulgaris
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne vulgaris
Timeline
- Start
- 2023-12-08
- Primary completion
- 2025-03-31
- Completion
- 2025-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DMT310 | Unknown | — | Topical |